House passes site-neutral policy, transparency, PBM reform package
(By Rachel Cohrs for STAT) WASHINGTON — The House passed a relatively major health care package late Monday, an end-of-year
Read More
Medicare Part D
Medicare bills pass House committee: 3 things to know
(By Rylee Wilson for Becker’s Hospital Review) The House Energy and Commerce Committee advanced 19 pieces of legislation Dec. 7,
Read MoreWhite House proposes to ‘march in’ on patents for costly drugs
(By Sydney Lupkin for NPR) The Biden administration is taking another crack at high prescription drug prices. This time its
Read MoreIs the Medicare Advantage ‘gold rush’ over?
(By Rylee Wilson for Becker’s Hospital Review) The Medicare Advantage gold rush is slowing down, Wall Street Journal columnist David
Read MoreColorado Blames Biden Team and Drugmakers for Delaying Canadian Imports
(By Phil Galewitz for KFF Health News) Colorado officials say their plan to import cheaper medicines from Canada has been
Read MoreThe Mark Cuban effect on drug pricing
(By Paige Twenter for Becker’s Hospital Review) In January 2022, entrepreneur and “Shark Tank” star Mark Cuban launched an online
Read MoreUncle Sam Wants You … to Help Stop Insurers’ Bogus Medicare Advantage Sales Tactics
(By Susan Jaffe for KFF Health News) After an unprecedented crackdown on misleading advertising claims by insurers selling private Medicare
Read MoreManufacturers need to be more open about a dangerous Alzheimer’s drug side effect
(By Madhav Thambisetty for STAT) Since the FDA’s approval of lecanemab (marketed as Leqembi) and Medicare’s recent decision to cover
Read MoreMedicare Advantage plans are not for everyone
There are many advantages to selecting a Medicare Advantage plan over traditional Medicare. Medicare Advantage plans have a limit on
Read MoreSen. Sanders pushes NIH to rein in drug prices
(By Sydney Lupkin for NPR) Can the National Institutes of Health bring down drug prices? It doesn’t approve new medicines
Read More